check_circleStudy Completed

Contraception, Heavy Menstrual Bleeding (HMB)

Relative BA 1st/4th and 2nd/3rd phase

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

45 - 75 Years
  • -

  • -

Trial summary

Enrollment Goal
36
Trial Dates
June 2006 - August 2006
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Natazia/Qlaira (EV/DNG, BAY86-5027)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Bayer Pharma AGBerlin, 13353, Germany

Trial design

Open label randomized single dose three way crossover two parallel group study to evaluate the relative bioavailability of the estradiol valerate and or dienogest tablet formulations contained in SH T00658ID versus suspensions, containing the same drugs after oral administration in healthy postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A